Protection by WR-2721 of the toxicity induced by the combination of cisplatin and 5-fluorouracil
- 31 December 1992
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 22 (4) , 785-789
- https://doi.org/10.1016/0360-3016(92)90524-l
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testingEuropean Journal of Cancer and Clinical Oncology, 1991
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990
- Schedule-dependency of in vivo modulation of 5-fluorouracil by leucovorin and uridine in murine colon carcinomaInvestigational New Drugs, 1989
- The Role of Drug Sequence in Therapeutic Selectivity of the Combination of 5-Fluorouracil and Cis-PlatinSelective Cancer Therapeutics, 1989
- Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapyPharmacology & Therapeutics, 1988
- Uridine-induced hypothermia in mice and rats in relation to plasma and tissue levels of uridine and its metabolitesCancer Chemotherapy and Pharmacology, 1987
- Hydrolysis of WR2721 by Mouse Liver Cell FractionsRadiation Research, 1987
- Alkaline Phosphatase Promotes Radioprotection and Accumulation of WR-1065 in V79-171 Cells Incubated in Medium Containing WR-2721International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1985
- The time course of radioprotection by WR 2721 in mouse skinInternational Journal of Radiation Oncology*Biology*Physics, 1982
- S-[2-(.omega.-Aminoalkylamino)ethyl] dihydrogen phosphorothioates and related compounds as potential antiradiation agentsJournal of Medicinal Chemistry, 1969